QQ客服 官方微博 反馈留言

	Retraction notice to “Gemcitabine and g-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma” International Journal of Pharmaceutics 478 (2015) 308–317 (S0378517314008679) (10.1016/j.ijpharm.2014.11.052))
	Sun L.; Zhou D.-S.; Zhang P.; Li Q.-H.; Liu P.
刊名	International Journal of Pharmaceutics
	2018
卷号	542期号:43102
DOI	10.1016/j.ijpharm.2018.03.016
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4583428
专题	山东大学
作者单位	1.Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, China 2.Department of Ortho
推荐引用方式 GB/T 7714	Sun L.,Zhou D.-S.,Zhang P.,et al. Retraction notice to “Gemcitabine and g-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma” International Journal of Pharmaceutics 478 (2015) 308–317 (S0378517314008679) (10.1016/j.ijpharm.2014.11.052))[J]. International Journal of Pharmaceutics,2018,542(43102).
APA	Sun L.,Zhou D.-S.,Zhang P.,Li Q.-H.,&Liu P..(2018).Retraction notice to “Gemcitabine and g-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma” International Journal of Pharmaceutics 478 (2015) 308–317 (S0378517314008679) (10.1016/j.ijpharm.2014.11.052)).International Journal of Pharmaceutics,542(43102).
MLA	Sun L.,et al."Retraction notice to “Gemcitabine and g-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma” International Journal of Pharmaceutics 478 (2015) 308–317 (S0378517314008679) (10.1016/j.ijpharm.2014.11.052))".International Journal of Pharmaceutics 542.43102(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。